Crescent Bioformulations Private Limited, a active private limited company, was established on 11 October 2011 in Kanpur, Uttar Pradesh, India. Engaging in industrial chemicals within the professional, scientific and technical sector, it holds CIN: U24233UP2011PTC046931. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.20 Cr and a paid-up capital of ₹7.63 M.
It upholds a compliant status. Its leadership includes Anurag Mishra (Director), Sagar Mishra (Director). Past directors included Lata Mishra, Prashant Tiwari, Anurag Bajpai. It holds ₹2.14 Cr open charges and ₹4.64 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 119/135, Darshan Purwa, Kanpur, Uttar Pradesh, 208012.
U24233UP2011PTC046931
046931
11 October 2011
₹1.20 Cr
₹7.63 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Crescent Bioformulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anurag Mishra | Director | 04 Dec 2017 | Current |
| Sagar Mishra | Director | 11 Oct 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 11 Jun 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 07 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Crescent Bioformulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.8% increase. The company also saw a substantial fall in profitability, with a 42.76% decrease in profit. The company's net worth moved up by a moderate rise of 2.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Crescent Bioformulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹21,380,000.00
₹46,350,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jun 2025 | Bank Of India | ₹2.00 Cr | Open |
| 26 Feb 2024 | Hdfc Bank Limited | ₹1.38 M | Open |
| 28 Dec 2023 | Sidbi | ₹1.00 Cr | Satisfied |
| 01 Dec 2021 | Sidbi | ₹3.85 M | Satisfied |
| 04 Aug 2020 | Sidbi | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Crescent Bioformulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Crescent Bioformulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crescent Bioformulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 28 Dec 2023 via Charge ID 100834455 with Sidbi was fully satisfied on 12 Jun 2025. was recorded as a recent event.
Progress on A charge registered on 01 Dec 2021 via Charge ID 100505675 with Sidbi was fully satisfied on 12 Jun 2025. was documented.
The activity A charge registered on 04 Aug 2020 via Charge ID 100356900 with Sidbi was fully satisfied on 12 Jun 2025. was completed.
Progress on A charge with Bank Of India amounted to Rs. 2.00 Cr with Charge ID 101108480 was registered on 02 Jun 2025. was documented.
Progress on Crescent Bioformulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Crescent Bioformulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
The CIN of Crescent Bioformulations Private Limited is U24233UP2011PTC046931.
Crescent Bioformulations Private Limited is headquartered at 119/135, Darshan Purwa, Kanpur, Uttar Pradesh, 208012.
Crescent Bioformulations Private Limited was incorporated on 11 October 2011.
The current directors of Crescent Bioformulations Private Limited are
The primary industry of Crescent Bioformulations Private Limited is Professional, Scientific And Technical.
Crescent Bioformulations Private Limited is unlisted.
The authorized capital of Crescent Bioformulations Private Limited is ₹1.20 Cr, and the paid-up capital is ₹7.63 M.
The compliance status of Crescent Bioformulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX